People
Paulo Costa
senior researcher
Email
pccosta@ff.up.pt
Phone number
-
ORCID
Ciência Vitae
Recent publications
- Teixeira, MI; Lopes, CM; Amaral, MH; Costa, PC. 2023. Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases. COLLOIDS AND SURFACES B-BIOINTERFACES, 221, DOI: 10.1016/j.colsurfb.2022.112999
- Ana Sofia Ferreira; Ana Margarida Silva; Diana Pinto; Manuela MMoreira; Ricardo Ferraz; Jaroslava Švarc-Gajić; Paulo CCosta; Cristina Delerue-Matos; Francisca Rodrigues. 2022. New Perspectives on the Sustainable Employment of Chestnut Shells as Active Ingredient against Oral Mucositis: A First Screening. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, DOI: 10.3390/ijms232314956
- Padrão, T., C. C. Coelho, P. Costa, N. Alegrete, F. J. Monteiro and S. R. Sousa. 2021. Combining local antibiotic delivery with heparinized nanohydroxyapatite/collagen bone substitute: A novel strategy for osteomyelitis treatment. Materials Science and Engineering B-Advanced Functional Solid-State Materials, DOI: 10.1016/j.msec.2020.111329
- Campos, J. C., D. Cunha, D. C. Ferreira, S. Reis and P. J. Costa. 2021. Oromucosal precursors of in loco hydrogels for wound-dressing and drug delivery in oral mucositis: Retain, resist, and release. Materials Science and Engineering B-Advanced Functional Solid-State Materials, DOI: 10.1016/j.msec.2020.111413
- A. C. Marques, P. C. Costa, S. Velho, M. H. Amaral. 2020. Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. JOURNAL OF CONTROLLED RELEASE, DOI: 10.1016/j.jconrel.2020.01.035
- M. I. Teixeira, C. M. Lopes, M. H. Amaral, P. C. Costa. 2020. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, DOI: 10.1016/j.ejpb.2020.01.005
- Salústio, PJ; Inácio, C; Nunes, T; Sousa e Silva, JP; Costa, PC. 2020. Flow characterization of a pharmaceutical excipient using the shear cell method. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 25(2), DOI: 10.1080/10837450.2019.1688348